[Pharmaceutical interventions in the new medicine service]

Area of Science:

• Pharmaceutical Sciences
• Clinical Pharmacy
• Health Services Research

Background:

• Community pharmacies play a crucial role in medication management.
• Dispensing new medications presents opportunities for pharmaceutical interventions.
• Understanding drug-related problems (DRPs) and negative medication outcomes (NOMs) is vital for patient safety.

Purpose of the Study:

• To describe pharmaceutical interventions during the dispensing of newly prescribed medications in community pharmacies.
• To identify and document drug-related problems (DRPs) and negative medication outcomes (NOMs) associated with new prescriptions.
• To assess the role of community pharmacists in clinical professional pharmacy services.

Main Methods:

• A descriptive observational study was conducted in two community pharmacies over six months.
• Data collected included patient demographics, medication details, and pharmaceutical interventions.
• The Dáder method was used to record drug-related problems (DRPs) and negative medication outcomes (NOMs).

Main Results:

• 258 new medications were dispensed to 251 patients, with an average age of 58.6 years.
• Patients used an average of 5.1 medications, with women representing 58.6% of participants.
• A negative medication outcome (NOM) was detected in 31.5% of patients, and 23 drug-related problems (DRPs) of non-adherence were documented.

Conclusions:

• The study demonstrates the value of pharmaceutical interventions in community pharmacy settings.
• Systematic documentation of interventions enhances pharmacist involvement in patient care.
• There is a clear need for greater integration of community pharmacies within the broader health system.